Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Jolly Good has developed and deployed VR-based digital therapeutics for mental health conditions such as depression and schizophrenia. Their solutions are being clinically evaluated in partnership with major pharmaceutical companies and academic institutions. Early results suggest improved patient engagement and potential efficacy as adjuncts to standard therapies. The company is actively pursuing PMDA regulatory approval in Japan[3][7].
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Jolly Good.